Oligoribonucleotides and Methods of Use Thereof for Treatment of Alopecia, Acute Renal Failure and Other Diseases

Details for Australian Patent Application No. 2012232948 (hide)

Owner Quark Pharmaceuticals, Inc.

Inventors Feinstein, Elena; Zurr, Daniel; Ehrlich, Shai

Agent Cullens

Pub. Number AU-A-2012232948

Parent 2005288522

Filing date 28 September 2012

Wipo publication date 18 October 2012

International Classifications

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/70 - Carbohydrates

Event Publications

18 October 2012 Application Open to Public Inspection

  Published as AU-A-2012232948

18 October 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012232949-Temporary bulkhead

2012232947-A Device